Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma.

British journal of cancer

Volumn 111, Issue 7, 2014, Pages 1293-1304

  Gkotzamanidou, M ^a   Sfikakis, P P ^a   Kyrtopoulos, S A ^a   Bamia, C ^a   Dimopoulos, M A ^a   Souliotis, V L ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; MELPHALAN;

ADULT; AGED; APOPTOSIS; ARTICLE; CASE CONTROL STUDY; CHROMATIN; DNA REPAIR; DRUG EFFECT; DRUG RESISTANCE; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MALE; MIDDLE AGED; MONONUCLEAR CELL; MULTIPLE MYELOMA; PATHOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CASE-CONTROL STUDIES; CHROMATIN; DNA REPAIR; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84910006819     PISSN: None     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.410     Document Type: Article

References (0)